CORT - Corcept Therapeutics GAAP EPS of $0.25 beats by $0.03 revenue of $146.81M beats by $5.61M
2024-05-01 16:52:34 ET
More on Corcept Therapeutics
- Corcept Therapeutics: Key Catalysts Ahead
- Corcept Therapeutics Incorporated (CORT) Q4 2023 Earnings Call Transcript
- Corcept Therapeutics Q1 2024 Earnings Preview
- Corcept falls after phase 3 results on Cushing's candidate doesn't include some data
- Seeking Alpha’s Quant Rating on Corcept Therapeutics